Trium Capital LLP Morpho Sys Ag Transaction History
Trium Capital LLP
- $350 Million
- Q3 2024
A detailed history of Trium Capital LLP transactions in Morpho Sys Ag stock. As of the latest transaction made, Trium Capital LLP holds 11,700 shares of MOR stock, worth $0. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,700Holding current value
$0% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MOR
# of Institutions
13Shares Held
1.8MCall Options Held
0Put Options Held
14.7K-
Black Rock Inc. New York, NY1.02MShares$00.0% of portfolio
-
Segantii Capital Management LTD463KShares$01.04% of portfolio
-
Tekla Capital Management LLC177KShares$00.05% of portfolio
-
Hennion & Walsh Asset Management, Inc.123KShares$00.0% of portfolio
-
Rhumbline Advisers Boston, MA5.19KShares$00.0% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...